hydroxyindoleacetic acid and alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol

hydroxyindoleacetic acid has been researched along with alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Korpinen, C; Matos, FF; Yocca, FD1

Other Studies

1 other study(ies) available for hydroxyindoleacetic acid and alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol

ArticleYear
5-HT1A receptor agonist effects of BMY-14802 on serotonin release in dorsal raphe and hippocampus.
    European journal of pharmacology, 1996, Dec-12, Volume: 317, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Dose-Response Relationship, Drug; Hippocampus; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Microdialysis; Piperazines; Pyridines; Pyrimidines; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists

1996